Pyxis Oncology, Inc.
PYXS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$77,331 | -$73,790 | -$120,717 | -$75,975 |
| Dep. & Amort. | $2,982 | $1,927 | $709 | $647 |
| Deferred Tax | $0 | $0 | $0 | $6,281 |
| Stock-Based Comp. | $12,945 | $16,946 | $15,764 | $6,441 |
| Change in WC | -$11,823 | -$11,664 | $4,501 | $6,676 |
| Other Non-Cash | $15,555 | -$4,128 | $10,408 | $20,604 |
| Operating Cash Flow | -$57,672 | -$70,709 | -$89,335 | -$35,326 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$237 | -$6,726 | -$6,399 | -$540 |
| Net Acquisitions | $0 | $6,660 | $0 | -$50 |
| Inv. Purchases | -$160,118 | -$196,831 | $0 | -$50 |
| Inv. Sales/Matur. | $168,510 | $92,048 | $0 | $50 |
| Other Inv. Act. | $0 | $0 | $0 | -$0 |
| Investing Cash Flow | $8,155 | -$104,849 | -$6,399 | -$590 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $59,046 | $6,122 | $0 | $152,296 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $280 | -$193 | $183 | $167 |
| Financing Cash Flow | $59,326 | $5,929 | $183 | $304,044 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $9,809 | -$169,629 | -$95,551 | $268,128 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,136 | $180,765 | $276,316 | $8,188 |
| End Cash | $20,945 | $11,136 | $180,765 | $276,316 |
| Free Cash Flow | -$57,909 | -$77,435 | -$95,734 | -$35,866 |